cV8 Diagnostic Ultrasound System vs LINQ II Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Samsung Healthcare
VS

AI Verdict

These tools are adjacent rather than direct competitors, as they address different aspects of cardiac care. The Samsung Medison cV8 is a diagnostic ultrasound system for real-time imaging and AI-assisted interpretation across various specialties, including fetal heart diagnosis. In contrast, the Medtronic LINQ II is an insertable cardiac monitor designed for long-term, continuous heart rhythm monitoring and arrhythmia detection.

Choose cV8 Diagnostic Ultrasound System if…

Choose the Samsung Medison cV8 Diagnostic Ultrasound System if your clinical practice requires a versatile, mobile ultrasound solution for real-time imaging across diverse specialties like obstetrics, neurology, and general radiology. It is ideal for scenarios demanding superior image clarity, AI-powered assistance for various measurements and diagnoses (e.g., fetal heart, nerve tracking), and streamlined workflow efficiency at the point of care.

View cV8 Diagnostic Ultrasound System →

Choose LINQ II Insertable Cardiac Monitor if…

Choose the Medtronic LINQ II Insertable Cardiac Monitor if you need a long-term, continuous heart rhythm monitoring solution for patients with suspected infrequent or asymptomatic arrhythmias, such as unexplained syncope, stroke, or atrial fibrillation. This device is best suited for remote patient management, offering AI-powered accuracy for arrhythmia detection and the convenience of remote programming and data transmission over several years.

View LINQ II Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature cV8 Diagnostic Ultrasound System LINQ II Insertable Cardiac Monitor
Pricing Varies Unknown
Deployment On-premise (hospital environments and outpatient diagnostic clinics) Subcutaneous implant with remote monitoring via mobile app or home communicator.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

cV8 Diagnostic Ultrasound System

Tool A's design explicitly addresses the clinician's direct interaction with the device through ergonomic features, a large LED monitor, a high-sensitivity touch panel, and dedicated workflow efficiency tools like EzExam+u2122 and EzPrepu2122. This directly enhances the day-to-day usability for the primary operator at the point of care.

Clinical Value

cV8 Diagnostic Ultrasound System

Tool A offers a broader and more immediate impact on diagnostic confidence and efficiency across *multiple* medical specialties due to its superior image quality and diverse AI-based real-time diagnostic assistance tools. While Tool B provides critical long-term monitoring for a specific condition, Tool A's features address a wider range of diagnostic needs at the point of care.

Pricing & Value

Tie

Both tools are high-value medical devices with opaque pricing models that require direct negotiation with the vendor. Without publicly available pricing information or details on total cost of ownership, it is impossible to definitively compare their pricing or overall value proposition.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

Tool B explicitly states its target size from 'Solo to large health systems' and boasts a proven track record with 'More than 1 million patients' globally, indicating robust scalability and widespread adoption. Its hybrid deployment model also suggests flexibility in integration compared to Tool A's on-premise hardware.

Innovation

cV8 Diagnostic Ultrasound System

Tool A presents a broader and more diverse application of AI for *real-time diagnostic assistance* across various imaging modalities and specialties, encompassing multiple dedicated AI-powered features. While Tool B's innovations in long-term monitoring and remote management are significant, Tool A's extensive suite of AI-driven diagnostic tools represents a more comprehensive innovation in the immediate diagnostic workflow.

Support & Docs

LINQ II Insertable Cardiac Monitor

Medtronic provides a more comprehensive and transparent array of support and documentation, particularly with its readily accessible patient education materials, user guides for its mobile app, and dedicated phone support lines for both patients and technical inquiries. This level of detail and accessibility for both clinicians and patients gives Tool B an edge.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature cV8 Diagnostic Ultrasound System LINQ II Insertable Cardiac Monitor
Name cV8 Diagnostic Ultrasound System LINQ II Insertable Cardiac Monitor
Company Samsung Medison Co. Medtronic
Description The Samsung Medison cV8 Diagnostic Ultrasound System is a premium, mobile, and software-controlled ultrasound system featuring advanced Crystal Architectureu2122 for superior image quality and AI-based diagnostic assistance tools like NerveTracku2122 and HeartAssistu2122 to enhance clinical confidence and workflow efficiency across diverse medical specialties. The Medtronic LINQ II is an advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias.
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Clinical Decision Support & Reference
Specialties Neurology, Obstetrics & Gynecology, Radiology Cardiology
Key Features (AI-based) NerveTracku2122 (nerve detection), UterineAssistu2122 (uterus measurement), BiometryAssistu2122 (fetal growth), ViewAssistu2122 (fetal annotation), HeartAssistu2122 (fetal heart diagnosis) AccuRhythmu2122 AI algorithms for enhanced accuracy, Innovative PVC detection algorithm

Videos

Demos, reviews, and walkthroughs featuring cV8 Diagnostic Ultrasound System and LINQ II Insertable Cardiac Monitor.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tool A, the cV8 Diagnostic Ultrasound System, is a versatile, mobile ultrasound solution for real-time imaging across diverse specialties like obstetrics, neurology, and general radiology, aiding in diagnoses such as fetal heart conditions and nerve detection. Tool B, the LINQ II Insertable Cardiac Monitor, is designed for long-term, continuous heart rhythm monitoring in adult and pediatric patients (ages 2 and older) experiencing infrequent symptoms that may suggest a cardiac arrhythmia, such as dizziness, palpitations, syncope, and chest pain.
Tool A's AI-based Intelligent Assist solutions, including NerveTracku2122, UterineAssistu2122, BiometryAssistu2122, ViewAssistu2122, and HeartAssistu2122, provide real-time diagnostic assistance for specific anatomical structures and conditions, aiming to increase confidence during ultrasound examinations. Tool B utilizes AccuRhythmu2122 AI algorithms to enhance the accuracy of arrhythmia detection and diagnosis, reducing false alerts for conditions like atrial fibrillation and pause, thereby improving diagnostic yield and clinician efficiency.
Tool A offers EzExam+u2122 and EzPrepu2122 for streamlined examination protocols, enhancing workflow efficiency during ultrasound scans, and features an ergonomic design for user convenience. Tool B features remote programming capability, allowing clinicians to optimize device settings without in-person visits, and facilitates data transmission via the MyCareLink Heartu2122 mobile app or MyCareLink Relayu2122 home communicator, reducing clinic workload and streamlining patient management.
Tool A features Crystal Architectureu2122 (CrystalBeamu2122, CrystalLiveu2122, S-Vue Single Crystal Transducersu2122) for superior image clarity and penetration, MV-Flowu2122 and LumiFlowu2122 for detailed microvascular blood flow visualization, and S-Shearwave Imagingu2122 for quantitative tissue stiffness assessment. Tool B provides up to 4.5 years of continuous monitoring, MRI compatibility (1.5 and 3.0T), and an innovative PVC detection algorithm for comprehensive cardiac rhythm analysis.
Tool B facilitates long-term patient management through its continuous monitoring for up to 4.5 years and remote data transmission via the MyCareLink Heartu2122 mobile app or MyCareLink Relayu2122 home communicator, enabling ongoing oversight of cardiac rhythms. Tool A offers S-Fusionu2122 technology for synchronous alignment of ultrasound images with other imaging modalities like MRI, enhancing diagnostic precision by combining different views.
AI Tool Finder
AI-powered search. Results may not be comprehensive.